November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis
Aug 12, 2024, 13:49

SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis

Icahn School of Medicine at Mount Sinai shared on X:

The SENTRY study, led by Dr. John Mascarenhas, is investigating the safety and efficacy of the combination of selinexor (Xpovio) plus ruxolitinib (Jakafi) for the treatment of patients with JAK inhibitor treatment-naive myelofibrosis.”

Read further.
Source: Icahn School of Medicine at Mount Sinai/X